Cabergoline Safety Questions, Cabergoline Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides information about Cabergoline side effects. Check out Health Surveys and Health Polls. If you have questions about Cabergoline, you can post them to our Doctors or Ask Patient Community about Cabergoline.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Help Community - Post Your Side Effect
Ask Our Doctors about Cabergoline
Cabergoline Safety Reports
Total Cabergoline reports: 145.Cabergoline FDA safety alerts: No.
Reported deaths: 10 Reported hospitalizations: 50.
Take Cabergoline Side Effects Survey or Share Your Cabergoline Story.
Reported Cabergoline Side Effects: mitral valve incompetence, cardiac valve disease, aortic valve incompetence, aortic valve sclerosis, oedema peripheral, interstitial lung disease, mitral valve disease, pleural effusion, heart valve insufficiency, pneumonia aspiration, nausea.
Cabergoline Usage.
Showing 1-50 of 145 Next >
Cabergoline Side Effects Report #5072976-3Physician from JAPAN reported CABERGOLINE problem on July 24, 2006. Male patient, 64 years of age, weighting 127.9 lb, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: cardiac failure, cardiomegaly, congestive cardiomyopathy, pleural effusion, pneumonia, pulmonary congestion, supraventricular tachycardia. CABERGOLINE dosage: 3 MG (1 IN 1 D), ORAL. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #5073000-9
CABERGOLINE problem was reported by a Physician from JAPAN on July 21, 2006. Male patient, 70 years of age, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: aspiration, dysphagia, interstitial lung disease, lung disorder, pleural effusion. CABERGOLINE dosage: 1 MG (0.25 MG,4 IN 1 D), ORAL. During the same period patient was treated with CARBIDOPA AND LEVODOPA, GASMOTIN, ARTANE, DOPS, SYMMETREL, SELBEX, SELEGILINE HYDROCHLORIDE, NAUZELIN. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #5073518-9
Physician from GERMANY reported CABERGOLINE problem on July 21, 2006. Male patient, 70 years of age, was diagnosed with restless legs syndrome and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: aortic valve incompetence, aortic valve sclerosis. CABERGOLINE dosage: 1 MG (DAILY),ORAL 7 YEARS AGO. Patient recovered.
Cabergoline Side Effects Report #5078069-3
CABERGOLINE problem was reported by a Physician from GERMANY on July 27, 2006. Female patient, 82 years of age, was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: colitis ischaemic, necrosis, ulcer. CABERGOLINE dosage: unknown. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #5078458-7
Physician from JAPAN reported CABERGOLINE problem on July 26, 2006. Male patient, 73 years of age, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: dementia, lung neoplasm malignant, oedema peripheral, respiratory failure. CABERGOLINE dosage: 1 MG (1 MG, 1 IN 1 D), ORAL. During the same period patient was treated with MENESIT. Patient was hospitalized. Patient died on 02/10/2004.
Cabergoline Side Effects Report #5079125-6
CABERGOLINE problem was reported by a Physician from JAPAN on July 27, 2006. Male patient, 79 years of age, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease, pleural effusion, pneumonia aspiration, pulmonary fibrosis, tuberculous pleurisy. CABERGOLINE dosage: 0.25 MG (0.25 MG, 1 IN 1 D), ORAL. During the same period patient was treated with PERINDOPRIL ERBUMINE, OLMETEC, LEVODOPA, SYMMETREL, NIVADIL, POSTERISANTE. Patient was hospitalized. Patient died on 07/19/2006.
Cabergoline Side Effects Report #5080135-3
Pharmacist from UNITED KINGDOM reported CABERGOLINE problem on July 31, 2006. Female patient was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased. CABERGOLINE dosage: 8 MG (4 MG, 2 IN 1 D), ORAL. During the same period patient was treated with AMANTADINE. Patient recovered.
Cabergoline Side Effects Report #5080687-3
CABERGOLINE problem was reported by a Physician from JAPAN on July 27, 2006. Female patient, 81 years of age, weighting 66.36 lb, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: hypoalbuminaemia, hypoproteinaemia, pleural effusion, pneumonia, respiratory failure. CABERGOLINE dosage: unknown. During the same period patient was treated with MENESIT, RABEPRAZOLE. Patient was hospitalized and became disabled. Patient recovered.
Cabergoline Side Effects Report #5080689-7
Consumer or non-health professional from UNITED KINGDOM reported CABERGOLINE problem on July 28, 2006. Male patient, 68 years of age, was diagnosed with restless legs syndrome and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: abdominal distension, oedema peripheral, weight increased. CABERGOLINE dosage: 2 MG (2 MG, 1 IN 1 D), ORAL. During the same period patient was treated with TEMAZEPAM. Patient recovered.
Cabergoline Side Effects Report #5080730-1
CABERGOLINE problem was reported by a Physician from JAPAN on July 27, 2006. Female patient was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: aortic valve disease. CABERGOLINE dosage: 2 MG (2 MG, 1 IN 1 D), ORAL. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #5080749-0
Health Professional from UNITED KINGDOM reported CABERGOLINE problem on July 31, 2006. Female patient was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: gastrointestinal carcinoma, metastases to lung. CABERGOLINE dosage: (2 MG) ORAL. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #5082036-3
CABERGOLINE problem was reported by a Physician from GERMANY on Aug 01, 2006. Male patient, 54 years of age, weighting 154.3 lb, was diagnosed with restless legs syndrome and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: aortic arteriosclerosis, asthenia, dilatation ventricular, ejection fraction decreased, mitral valve incompetence, mitral valve sclerosis. CABERGOLINE dosage: 1 MG (1 IN 1 D), ORAL. During the same period patient was treated with CARVEDILOL, DIOVAN HCT, SPIRONOLACTONE, ZOCOR, TORSEMIDE. Patient recovered.
Cabergoline Side Effects Report #5082099-5
Physician from GERMANY reported CABERGOLINE problem on July 31, 2006. Male patient, 70 years of age, weighting 176.4 lb, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: accidental overdose, ascites, blood creatine phosphokinase increased, c-reactive protein increased, dyskinesia, pyrexia, somnolence. CABERGOLINE dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, DIPYRONE, TRAMADOL. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #5083046-2
CABERGOLINE problem was reported by a Physician from GERMANY on Aug 02, 2006. Male patient was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: cardiac valve disease, fibrosis. CABERGOLINE dosage: unknown. Patient recovered.
Cabergoline Side Effects Report #5084300-0
Health Professional from UNITED STATES reported CABERGOLINE problem on Aug 17, 2006. Female patient was diagnosed with pituitary tumour benign and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: dizziness, nausea, vomiting. CABERGOLINE dosage: 0.5 MG 1/2 TAB 2X/WEEK PO. Patient recovered.
Cabergoline Side Effects Report #5085931-4
CABERGOLINE problem was reported by a Physician from JAPAN on Aug 02, 2006. Male patient, 77 years of age, weighting 127.9 lb, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: c-reactive protein increased, collagen disorder, interstitial lung disease, oral intake reduced, oxygen saturation decreased, pneumonia aspiration, pneumonia bacterial, rheumatoid factor positive. CABERGOLINE dosage: 2 MG (1 MGL 2 IN 1 D), ORAL. During the same period patient was treated with LEVODOPA. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #5085942-9
Health Professional from UNITED KINGDOM reported CABERGOLINE problem on Aug 03, 2006. Female patient was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, parkinson's disease. CABERGOLINE dosage: unknown. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #5085990-9
CABERGOLINE problem was reported by a Physician from JAPAN on Aug 02, 2006. Female patient, 74 years of age, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: cardiac failure, condition aggravated, disseminated intravascular coagulation, dyspnoea, mitral valve incompetence, oedema peripheral, pulmonary hypertension, pulmonary oedema, tricuspid valve incompetence. CABERGOLINE dosage: 4 MG (4 MG, 1 IN 1 D), ORAL. During the same period patient was treated with LEVODOPA. Patient was hospitalized. Patient died.
Cabergoline Side Effects Report #5086014-X
Pharmacist from SPAIN reported CABERGOLINE problem on Aug 07, 2006. Female patient, 55 years of age, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: aortic valve incompetence, cardiac failure, pulmonary hypertension, tricuspid valve incompetence. CABERGOLINE dosage: 4 MG (1 MG), ORAL. During the same period patient was treated with SELEGILINE, LEVODOPA, BENSERAZIDE, CARBIDOPA. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #5086138-7
CABERGOLINE problem was reported by a Physician from JAPAN on Aug 09, 2006. Male patient, 80 years of age, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: pneumonia aspiration. CABERGOLINE dosage: 0.25 MG, ORAL. During the same period patient was treated with ASPIRIN, DILTIAZEM HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #5086999-1
Consumer or non-health professional from GERMANY reported CABERGOLINE problem on Aug 11, 2006. Male patient was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: constipation. CABERGOLINE dosage: (1 MG), ORAL. Patient recovered.
Cabergoline Side Effects Report #5087059-6
CABERGOLINE problem was reported by a Physician from UNITED KINGDOM on Aug 10, 2006. Female patient was diagnosed with hyperprolactinaemia and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: accidental overdose, blood prolactin decreased, breast cyst. CABERGOLINE dosage: unknown. Patient recovered.
Cabergoline Side Effects Report #5087061-4
Physician from GERMANY reported CABERGOLINE problem on Aug 08, 2006. Male patient was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: antinuclear antibody increased, aortic valve sclerosis, mitral valve sclerosis, oedema peripheral, tricuspid valve sclerosis. CABERGOLINE dosage: unknown. Patient recovered.
Cabergoline Side Effects Report #5087115-2
CABERGOLINE problem was reported by a Physician from GERMANY on Aug 10, 2006. Female patient, 69 years of age, was diagnosed with restless legs syndrome and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: aortic valve incompetence, aortic valve sclerosis, biliary cirrhosis primary. CABERGOLINE dosage: 1 MG (DAILY) ORAL. During the same period patient was treated with URSOFALK. Patient recovered.
Cabergoline Side Effects Report #5091326-X
Physician from JAPAN reported CABERGOLINE problem on Aug 15, 2006. Female patient, 81 years of age, weighting 66.36 lb, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: hypoalbuminaemia, hypoproteinaemia, pleural effusion, pneumonia, respiratory failure. CABERGOLINE dosage: unknown. During the same period patient was treated with MENESIT, RABEPRAZOLE. Patient was hospitalized and became disabled. Patient recovered.
Cabergoline Side Effects Report #5091625-1
CABERGOLINE problem was reported by a Physician from GERMANY on Aug 16, 2006. Female patient, 82 years of age, weighting 165.3 lb, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: acute abdomen, colitis ischaemic, disease progression, haematemesis, nausea, pneumonia, staphylococcal sepsis. CABERGOLINE dosage: 0.5 MG (1 IN 1 D); ORAL. During the same period patient was treated with CITALOPRAM HYDROBROMIDE, CIPROFLOXACIN. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #5091684-6
Pharmacist from JAPAN reported CABERGOLINE problem on Aug 09, 2006. Female patient was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: platelet count decreased. CABERGOLINE dosage: unknown. During the same period patient was treated with NEO DOPASTON, ARTANE, SYMMETREL. Patient recovered.
Cabergoline Side Effects Report #5094391-9
CABERGOLINE problem was reported by a Physician from GERMANY on Aug 16, 2006. Female patient, 75 years of age, weighting 176.4 lb, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: aortic valve incompetence, aortic valve sclerosis, hypertensive heart disease, mitral valve incompetence. CABERGOLINE dosage: 2 MG (DAILY), ORAL. During the same period patient was treated with MADOPAR, BISOPROLOL, HYDROCHLOROTHIAZIDE. Patient recovered.
Cabergoline Side Effects Report #5094396-8
Physician from DENMARK reported CABERGOLINE problem on Aug 16, 2006. Male patient, 73 years of age, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: aortic valve sclerosis, dyspnoea, mitral valve incompetence, mitral valve sclerosis, pleural fibrosis. CABERGOLINE dosage: 6 MG (DAILY), ORAL. During the same period patient was treated with CORODIL, COMTESS, SINEMET. Patient recovered.
Cabergoline Side Effects Report #5097066-5
CABERGOLINE problem was reported by a Physician from AUSTRALIA on Aug 23, 2006. Female patient, 54 years of age, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: oedema peripheral, red blood cell sedimentation rate increased, retroperitoneal fibrosis. CABERGOLINE dosage: 4 MG (4 MG, 1 D), ORAL. Patient recovered.
Cabergoline Side Effects Report #5099766-X
Pharmacist from JAPAN reported CABERGOLINE problem on Aug 24, 2006. Female patient was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: haemorrhage. CABERGOLINE dosage: unknown. Patient recovered.
Cabergoline Side Effects Report #5100675-8
CABERGOLINE problem was reported by a Consumer or non-health professional from DENMARK on Aug 24, 2006. Female patient, 60 years of age, was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: bradycardia, cardiac procedure complication, chest discomfort, dyspnoea, electrocardiogram abnormal, heart rate irregular, mitral valve incompetence, mitral valve stenosis. CABERGOLINE dosage: 10 MG DAILY, ORAL. During the same period patient was treated with GABAPENTIN, SINEMET, PAMOL, MANDOLGIN, REQUIP, CENTYL MITE W, PERMAX, SIFROL. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #5101313-0
Physician from JAPAN reported CABERGOLINE problem on Aug 21, 2006. Male patient, 71 years of age, weighting 130.1 lb, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: dysphagia, interstitial lung disease, lung disorder, pleural effusion, pneumonia aspiration. CABERGOLINE dosage: 5 MG (0.25 MG, 4 IN 1 D), ORAL. During the same period patient was treated with LEVODOPA, GASMOTIN, ARTANE, DOPS, SYMMETREL, SELBEX, SELEGILINE HYDROCHLORIDE, NAUZELIN. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #5101366-X
CABERGOLINE problem was reported by a Physician from JAPAN on Aug 21, 2006. Male patient, 71 years of age, weighting 130.1 lb, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: dysphagia, interstitial lung disease, lung disorder, pleural effusion, pneumonia aspiration, productive cough. CABERGOLINE dosage: 5 MG (0.25 MG, 4 IN 1 D), ORAL. During the same period patient was treated with LEVODOPA, GASMOTIN, ARTANE, DOPS, SYMMETREL, SELBEX, SELEGILINE HYDROCHLORIDE, NAUZELIN. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #5102783-4
Consumer or non-health professional from DENMARK reported CABERGOLINE problem on Aug 28, 2006. Male patient, 56 years of age, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: cough, dyspnoea, emphysema, increased upper airway secretion, interstitial lung disease, pleurisy, pulmonary fibrosis, pulmonary function test decreased. CABERGOLINE dosage: unknown. During the same period patient was treated with ELDEPRYL, REQUIP, SINEMET, COMTESS, SIFROL. Patient recovered.
Cabergoline Side Effects Report #5104134-8
CABERGOLINE problem was reported by a Consumer or non-health professional from DENMARK on Aug 28, 2006. Female patient, 41 years of age, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: cardiac failure, dyspnoea, mitral valve incompetence, mitral valve stenosis, obstruction, obstructive airways disorder, total lung capacity decreased. CABERGOLINE dosage: 4 MG (DAILY), ORAL. During the same period patient was treated with MADOPAR. Patient recovered.
Cabergoline Side Effects Report #5106178-9
Physician from JAPAN reported CABERGOLINE problem on Aug 08, 2006. Female patient, 28 years of age, was diagnosed with hyperprolactinaemia, stomach discomfort and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: haemorrhage subcutaneous, increased tendency to bruise, platelet count decreased, prothrombin time prolonged. CABERGOLINE dosage: unknown. During the same period patient was treated with GASMOTIN. Patient recovered.
Cabergoline Side Effects Report #5106182-0
CABERGOLINE problem was reported by a Pharmacist from JAPAN on Aug 30, 2006. Male patient, 61 years of age, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: rhabdomyolysis. CABERGOLINE dosage: unknown. During the same period patient was treated with MEILAX, PAXIL, MUCOSTA, SIFROL, ARTANE, SYMMETREL. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #5106231-X
Physician from GERMANY reported CABERGOLINE problem on Aug 30, 2005. Male patient was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: antinuclear antibody increased, aortic valve sclerosis, incorrect dose administered, mitral valve sclerosis, oedema peripheral, tricuspid valve sclerosis. CABERGOLINE dosage: unknown. Patient recovered.
Cabergoline Side Effects Report #5109766-9
CABERGOLINE problem was reported by a Physician from UNITED KINGDOM on Sept 06, 2006. Female patient was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: psychotic disorder. CABERGOLINE dosage: 4 MG, ORAL. Patient recovered.
Cabergoline Side Effects Report #5112586-2
Pharmacist from JAPAN reported CABERGOLINE problem on Sept 07, 2006. Female patient was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: depression, suicidal ideation, tremor. CABERGOLINE dosage: unknown. Patient recovered.
Cabergoline Side Effects Report #5118559-8
CABERGOLINE problem was reported by a Physician from AUSTRALIA on Sept 14, 2006. Male patient, 70 years of age, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: agitation, hallucinations, mixed. CABERGOLINE dosage: 0.5 MG (0.5 MG, 1 IN 1 D), ORAL. During the same period patient was treated with LITHIUM, ENDEP, OROXINE, PRESSIN, LITHICARB. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #5118741-X
Physician from AUSTRALIA reported CABERGOLINE problem on Sept 14, 2006. Female patient, 54 years of age, weighting 176.4 lb, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: oedema peripheral, red blood cell sedimentation rate increased, retroperitoneal fibrosis. CABERGOLINE dosage: 4 MG (4MG, 1 IN 1 D), ORAL. Patient recovered.
Cabergoline Side Effects Report #5119966-X
CABERGOLINE problem was reported by a Physician from JAPAN on Sept 19, 2006. Male patient was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: platelet count decreased. CABERGOLINE dosage: 2 MG (2 MG, 1 IN 1 D), ORAL. During the same period patient was treated with SINEMET, TRIHEXYPHENIDYL, AMANTADINE. Patient recovered.
Cabergoline Side Effects Report #5119969-5
Physician from GERMANY reported CABERGOLINE problem on Sept 19, 2006. Female patient was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: aortic valve incompetence, condition aggravated. CABERGOLINE dosage: unknown. Patient recovered.
Cabergoline Side Effects Report #5119974-9
CABERGOLINE problem was reported by a Physician from JAPAN on Sept 20, 2006. Male patient, 73 years of age, weighting 90.39 lb, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: anorexia, emphysema, interstitial lung disease, pharyngeal erythema, pharyngolaryngeal pain. CABERGOLINE dosage: 0.5 MG (0.25 MG, 2 IN 1 D), ORAL. During the same period patient was treated with AMLODIPINE BESILATE, CANDESARTAN CILEXETIL, TICLOPIDINE, NICERGOLINE, IBUDILAST. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #5120033-X
Physician from GERMANY reported CABERGOLINE problem on Sept 18, 2006. Female patient, 69 years of age, was diagnosed with restless legs syndrome and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: aortic arteriosclerosis, aortic valve incompetence, aortic valve sclerosis. CABERGOLINE dosage: 1 MG (1 D), ORAL. During the same period patient was treated with URSO FALK, ACETYLSALICYLIC ACID SRT. Patient recovered.
Cabergoline Side Effects Report #5121323-7
CABERGOLINE problem was reported by a Health Professional from UNITED KINGDOM on Sept 20, 2006. Female patient was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: dyspnoea, gastrointestinal carcinoma, metastases to lung. CABERGOLINE dosage: 2.5 MG, ORAL. During the same period patient was treated with CODEINE PHOSPHATE, PROCYCLIDINE HYDROCHLORIDE, OMEPRAZOLE, DEXAMETHASONE, ATENOLOL, BENDROFLUMETHIAZIDE. Patient was hospitalized. Patient died on 09/03/2006.
Cabergoline Side Effects Report #5127987-6
Physician from JAPAN reported CABERGOLINE problem on Sept 27, 2006. Male patient, 82 years of age, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: aortic valve disease, aortic valve incompetence, blood pressure diastolic decreased, cardiac murmur, cardiomegaly, mitral valve disease, mitral valve incompetence, oedema peripheral, pulmonary congestion. CABERGOLINE dosage: unknown. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #5128340-1
CABERGOLINE problem was reported by a Consumer or non-health professional from GERMANY on Sept 28, 2006. Male patient was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: cardiac disorder, cardiovascular disorder, constipation, gastric disorder, intestinal obstruction, nausea. CABERGOLINE dosage: 1 MG, ORAL. Patient recovered.
Showing 1-50 of 145 Next >